Related Experiment Video
Updated: Mar 24, 2026

Preparation and Culture of Rat Lens Epithelial Explants for Studying Terminal Differentiation
Published on: September 22, 2009
Effect of NF-κB p65 antisense oligodeoxynucleotide on transdifferentiation of normal human lens epithelial cells
Chao Liu1, Xiao-Li Wu2, Xin-Yi Wu3
1Department of Ophthalmology, Qilu Hospital, Shandong University, Jinan 250012, Shandong Province, China; Department of Ophthalmology, Central Hospital of Qingdao, Qingdao 266042, Shandong Province, China.
Aim:
To study the inhibition of nuclear factor kappa-B p65 (NF-κB p65) antisense oligodeoxynucleotide (ASODN) on transdifferentiation of normal human lens epithelial cells induced by transforming growth factor-β2 (TGF-β2) in vitro.
Methods:
NF-κB p65 ASODN and NF-κB p65 missense oligodeoxynucleotide (MSODN) were designed and synthesized. Human lens epithelial cell line (HLE B-3) cells were prepared for study and divided into 7 groups. Control group was HLE B-3 cells cultured in vitro in dulbecco's modified eagle medium (DMEM). T1, T2, and T3 group were HLE B-3 cells cultured in vitro in DMEM with 10 ng/mL TGF-β2 for 6h, 12h, 24h respectively. A+T group was HLE B-3 cells cultured with 10 ng/mL TGF-β2 for 24h after transfected by NF-κB p65 ASODN for 24h. M+T group was HLE B-3 cells cultured with 10 ng/mL TGF-β2 for 24h after transfected by NF-κB p65 MSODN for 24h. The negative control group was HLE B-3 cells cultured with 10 ng/mL TGF-β2 for 24h after cultured with transfer agent (HiPerFect) for 24h. Cell morphology was observed at different time points using an inverted microscope. The expression of NF-κB p65 mRNA was detected with reverse transcription-polymerase chain reaction (RT-PCR), and the expression of α-smooth muscle actin (α-SMA) protein was assayed with ELISA.
Results:
With the TGF-β2 stimulation prolongation, the expression of NF-κB p65 mRNA and α-SMA protein increased in T1, T2, T3 groups compared with the control group, and the difference was statistically significant (P<0.05). NF-κB p65 ASODN lowered the expression of NF-κB p65 mRNA and α-SMA protein induced by TGF-β2. NF-κB p65 MSODN and HiPerFect did not lower the expression of NF-κB p65 mRNA and α-SMA protein induced by TGF-β2. The difference between control group and A+T group was not statistically significant (P>0.05), but the difference among A+T group and other groups was statistically significant (P<0.05).
Conclusion:
NF-κB p65 ASODN could lower the expression of NF-κB p65 mRNA and α-SMA protein induced by TGF-β2, and antagonized TGF-β2-induced transdifferentiation of HLE B-3 in vitro. NF-κB p65 ASODN could be used as a new biological therapeutic target of posterior capsular opacification.
Insights
Nuclear factor kappa-B p65 antisense oligodeoxynucleotide (NF-κB p65 ASODN) inhibited transforming growth factor-β2 (TGF-β2)-induced transdifferentiation in human lens epithelial cells. This suggests NF-κB p65 ASODN may be a therapeutic target for posterior capsular opacification.
Area of Science:
- Ophthalmology
- Cell Biology
- Molecular Biology
Background:
- Posterior capsular opacification (PCO) is a common complication after cataract surgery.
- Transforming growth factor-β2 (TGF-β2) is implicated in the transdifferentiation of lens epithelial cells, a key process in PCO development.
- Nuclear factor kappa-B p65 (NF-κB p65) signaling pathway activation is observed during TGF-β2-induced transdifferentiation.
Purpose of the Study:
- To investigate the inhibitory effect of NF-κB p65 antisense oligodeoxynucleotide (ASODN) on TGF-β2-induced transdifferentiation of human lens epithelial cells (HLE B-3) in vitro.
- To evaluate NF-κB p65 ASODN as a potential therapeutic target for PCO.
Main Methods:
- Human lens epithelial cells (HLE B-3) were treated with TGF-β2 to induce transdifferentiation.
- Cells were transfected with NF-κB p65 ASODN or a missense control oligodeoxynucleotide (MSODN).
- Expression levels of NF-κB p65 mRNA and α-smooth muscle actin (α-SMA) protein were quantified using RT-PCR and ELISA, respectively.
Main Results:
- TGF-β2 significantly increased the expression of NF-κB p65 mRNA and α-SMA protein in a time-dependent manner.
- NF-κB p65 ASODN treatment significantly reduced the expression of both NF-κB p65 mRNA and α-SMA protein induced by TGF-β2.
- NF-κB p65 MSODN and the transfer agent HiPerFect did not show significant inhibitory effects.
Conclusions:
- NF-κB p65 ASODN effectively antagonizes TGF-β2-induced transdifferentiation of human lens epithelial cells in vitro.
- The findings support NF-κB p65 ASODN as a promising therapeutic target for preventing or treating posterior capsular opacification.
More Related Videos
Related Concept Videos
TGF - β Signaling Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Forced Transdifferentiation
Artificial...

